Cipla’s arm incorporates new wholly owned subsidiary in Germany

30 May 2025 Evaluate

Cipla’s wholly owned subsidiary -- Cipla (EU), UK has incorporated a new wholly owned subsidiary named ‘CiplaRna GmbH’ in Germany, effective May 28, 2025. CiplaRna has been incorporated with the objective of establishing a laboratory for mRNA-based formulation and drug development support.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.


Cipla Share Price

1341.45 12.40 (0.93%)
20-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1724.45
Dr. Reddys Lab 1280.30
Cipla 1341.45
Zydus Lifesciences 901.00
Lupin 2219.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×